Exact Mass: 315.12929260000004

Exact Mass Matches: 315.12929260000004

Found 88 metabolites which its exact mass value is equals to given mass value 315.12929260000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Neosaxitoxin

[(4R,10aS,10bS)-2-amino-5,10,10-trihydroxy-6-imino-3H,4H,5H,6H,8H,9H,10H,10bH-pyrrolo[1,2-c]purin-4-yl]methyl carbamate

C10H17N7O5 (315.1291112)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Neosaxitoxin is produced by Protogonyaulax and found in shellfis D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

N'-Hydroxysaxitoxin

{10,10-dihydroxy-2,6-diimino-hexahydro-1H-pyrrolo[1,2-c]purin-4-yl}methyl N-hydroxycarbamate

C10H17N7O5 (315.1291112)


N-Hydroxysaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.

   

6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol

6-amino-9-benzyl-2-(2-methoxyethoxy)-8,9-dihydro-7H-purin-8-one

C15H17N5O3 (315.1331332)


   

Di-deacetyl adrogolide

15-propyl-14-thia-11-azatetracyclo[8.7.0.0^{2,7}.0^{13,17}]heptadeca-2,4,6,13(17),15-pentaene-4,5-diol

C18H21NO2S (315.12929260000004)


   

Antramycin

3-{8,11-dihydroxy-12-methyl-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}prop-2-enimidate

C16H17N3O4 (315.1219002)


   

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

N-[5-fluoro-2-(piperidin-1-yl)phenyl]pyridine-4-carbothioamide

C17H18FN3S (315.12054000000006)


   
   

18,19-Dihydroangustine

18,19-Dihydroangustine

C20H17N3O (315.1371552)


   
   

3,14-Dihydroangustine

3,14-Dihydroangustine

C20H17N3O (315.1371552)


   
   

ANTHRAMYCIN

ANTHRAMYCIN

C16H17N3O4 (315.1219002)


A member of the class of pyrrolobenzodiazepines that is (11aS)-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine substituted at positions 2, 5, 8, 9 and 11R by a (1E)-3-amino-3-oxoprop-1-en-1-yl, oxo, methyl, hydroxy and hydroxy groups, respectively. It is a natural product isolated from Streptomyces refuineus subsp. thermotolerans. D000970 - Antineoplastic Agents

   
   

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

C10H17N7O5 (315.1291112)


   
   
   
   
   
   
   

2,6-bis(phenylmethoxy)benzonitrile

2,6-bis(phenylmethoxy)benzonitrile

C21H17NO2 (315.1259222)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

C17H18FN3O2 (315.138298)


   

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

C17H18FN3O2 (315.138298)


   

BENZYL 2,4-DIOXO-3,4,5,6,8,9-HEXAHYDRO-1H-PYRIMIDO[4,5-D]AZEPINE-7(2H)-CARBOXYLATE

BENZYL 2,4-DIOXO-3,4,5,6,8,9-HEXAHYDRO-1H-PYRIMIDO[4,5-D]AZEPINE-7(2H)-CARBOXYLATE

C16H17N3O4 (315.1219002)


   

1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

C16H17N3O4 (315.1219002)


   

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

C18H21NO2S (315.12929260000004)


   

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

C15H19F2NO4 (315.1282078)


   

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

C15H19F2NO4 (315.1282078)


   

2-Oxazolidinone,4,5,5-triphenyl-

2-Oxazolidinone,4,5,5-triphenyl-

C21H17NO2 (315.1259222)


   

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

C13H22BNO5S (315.13116720000005)


   

Benzyl 2-Fluoro-4-Morpholinobenzoate

Benzyl 2-Fluoro-4-Morpholinobenzoate

C18H18FNO3 (315.127065)


   

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

C14H21NO7 (315.13179560000003)


   
   
   

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

C21H17NO2 (315.1259222)


   
   

Antramycin

ANTHRAMYCIN

C16H17N3O4 (315.1219002)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

Doxepin hydrochloride

(E)-doxepin hydrochloride

C19H22ClNO (315.13898320000004)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2]. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].
. Doxepin has therapeutic effects in atopic dermatitis,chronic urticarial,can improve cognitive processes, protect central nervous system[4].
. Doxepin has also been proposed as a protective factor against oxidative stress[5].
.

   

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

C15H19F2NO4 (315.1282078)


   
   

4-[(4-methoxybenzylidene)amino]azobenzene

4-[(4-methoxybenzylidene)amino]azobenzene

C20H17N3O (315.1371552)


   

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

C19H22ClNO (315.13898320000004)


   

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

C20H17N3O (315.1371552)


   

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

C15H22ClNO4 (315.1237282)


   

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

C16H15F2N5 (315.1295454)


   

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

C17H18FN3S (315.12054000000006)


   

Pyridoxal 4-methoxybenzoyl hydrazone

Pyridoxal 4-methoxybenzoyl hydrazone

C16H17N3O4 (315.1219002)


   

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

C20H17N3O (315.1371552)


   
   
   

Pyroglutamyltryptophan

Pyroglutamyltryptophan

C16H17N3O4 (315.1219002)


   

N1-neopentyl-2-[1-(3,5-difluoro-2-hydroxyphenyl)ethylidene]hydrazine-1-carbothioamide

N1-neopentyl-2-[1-(3,5-difluoro-2-hydroxyphenyl)ethylidene]hydrazine-1-carbothioamide

C14H19F2N3OS (315.12168280000003)


   

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

C20H17N3O (315.1371552)


   

5-[(4-Methoxy-2-methylanilino)methylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[(4-Methoxy-2-methylanilino)methylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C16H17N3O4 (315.1219002)


   

N-(3-methoxypropyl)-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

N-(3-methoxypropyl)-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

C16H17N3O4 (315.1219002)


   

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

C20H17N3O (315.1371552)


   
   

N-[(3,4,5-trimethoxyphenyl)methylideneamino]pyridine-3-carboxamide

N-[(3,4,5-trimethoxyphenyl)methylideneamino]pyridine-3-carboxamide

C16H17N3O4 (315.1219002)


   
   
   
   

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

C15H17N5O3 (315.1331332)


   

N-[(E)-(2,5-Dimethoxyphenyl)methylideneamino]-1-methyl-6-oxopyridine-3-carboxamide

N-[(E)-(2,5-Dimethoxyphenyl)methylideneamino]-1-methyl-6-oxopyridine-3-carboxamide

C16H17N3O4 (315.1219002)


   
   

Neosaxitoxin

Neosaxitoxin

C10H17N7O5 (315.1291112)


A pyrrolopurine that is saxitoxin carrying a hydroxy substituent on the nitrogen atom at position 5. It is a sodium channel blocker that is undergoing clinical trials as a prolonged-duration local anesthetic.

   
   
   

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291112)


   

9-{3h-pyrrolo[2,3-c]quinolin-4-ylmethyl}purin-6-amine

9-{3h-pyrrolo[2,3-c]quinolin-4-ylmethyl}purin-6-amine

C17H13N7 (315.1232378)


   

(3s,8as)-3-{[(3r)-2,3-dihydroxyindol-3-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3s,8as)-3-{[(3r)-2,3-dihydroxyindol-3-yl]methyl}-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C16H17N3O4 (315.1219002)


   

5-hydroxy-6-(1h-indol-3-ylmethyl)-1,6-dimethoxy-3-methylidenepyrazin-2-one

5-hydroxy-6-(1h-indol-3-ylmethyl)-1,6-dimethoxy-3-methylidenepyrazin-2-one

C16H17N3O4 (315.1219002)


   

3-[1-(3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl)ethyl]-3-hydroxy-1-methylindol-2-one

3-[1-(3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl)ethyl]-3-hydroxy-1-methylindol-2-one

C16H17N3O4 (315.1219002)


   

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291112)


   

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291112)


   

(3r)-3-[(1r)-1-[(2s)-3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3r)-3-[(1r)-1-[(2s)-3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C16H17N3O4 (315.1219002)


   

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

C21H17NO2 (315.1259222)


   

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291112)


   

(3s)-3-[(1r)-1-[(2s)-3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3s)-3-[(1r)-1-[(2s)-3,6-dihydroxy-5-methylidene-2h-pyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C16H17N3O4 (315.1219002)


   

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291112)


   

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

C15H17N5O3 (315.1331332)


   

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

C15H17N5O3 (315.1331332)